EVM005: An Ectromelia-Encoded Protein with Dual Roles in NF-κB Inhibition and Virulence

PLoS Pathogens

Volumn 10, Issue 8, 2014, Pages

  van Buuren, Nicholas ^a   Burles, Kristin ^a   Schriewer, Jill ^b   Mehta, Ninad ^a   Parker, Scott ^b   Buller, R Mark ^b   Barry, Michele ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; EVM005 PROTEIN; F BOX PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; ECTROMELIA VIRUS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREGULATION; MOUSE; MOUSEPOX; NONHUMAN; OPEN READING FRAME; ORTHOPOXVIRUS; POXVIRUS INFECTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS VIRULENCE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VIRULENCE;

ANIMALS; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; FLOW CYTOMETRY; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL PROTEINS; VIRULENCE;

EID: 84907519688     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004326     Document Type: Article

References (61)

1. Hayden MS, Ghosh S, (2008) Shared principles in NF-kappaB signaling. Cell 132: 344–362.
2. Vallabhapurapu S, Karin M, (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693–733.
3. Hiscott J, Kwon H, Genin P, (2001) Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest 107: 143–151.
4. Hiscott J, Nguyen TL, Arguello M, Nakhaei P, Paz S, (2006) Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25: 6844–6867.
5. Mohamed MR, McFadden G, (2009) NFkB inhibitors: strategies from poxviruses. Cell Cycle 8: 3125–3132.
6. Cahir McFarland ED, Izumi KM, Mosialos G, (1999) Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18: 6959–6964.
7. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J, (1995) Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev 59: 481–505.
8. Ramachandran A, Horvath CM, (2009) Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res 29: 531–537.
9. Powell PP, Dixon LK, Parkhouse RM, (1996) An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol 70: 8527–8533.
10. Moss B (1996) Poxviridae: The Viruses and Their Replication. In: B.N. Fields DMK PMH, editor. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott - Raven Publishers.
11. Fenner F (1996) Poxviruses. In: Fields B, Howley, PM, editor. Fields Virology. 3rd ed. Philadelphia, PA: Lippincott - Raven Publishers.
12. Johnston JB, McFadden G, (2003) Poxvirus immunomodulatory strategies: current perspectives. J Virol 77: 6093–6100.
13. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, et al. (2003) Poxviruses and immune evasion. Annu Rev Immunol 21: 377–423.
14. Smith CA, Davis T, Wignall JM, Din WS, Farrah T, et al. (1991) T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 176: 335–342.
15. Upton C, Macen JL, Schreiber M, McFadden G, (1991) Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184: 370–382.
16. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, et al. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97: 10162–10167.
17. Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, et al. (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201: 1007–1018.
18. Schroder M, Baran M, Bowie AG, (2008) Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J 27: 2147–2157.
19. Chen RA, Ryzhakov G, Cooray S, Randow F, Smith GL, (2008) Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4: e22.
20. DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, et al. (2004) Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279: 36570–36578.
21. Gedey R, Jin XL, Hinthong O, Shisler JL, (2006) Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. J Virol 80: 8676–8685.
22. Shisler JL, Jin XL, (2004) The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol 78: 3553–3560.
23. Hinthong O, Jin XL, Shisler JL, (2008) Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection. Virology 373: 248–262.
24. Mansur DS, Maluquer de Motes C, Unterholzner L, Sumner RP, Ferguson BJ, et al. (2013) Poxvirus targeting of E3 ligase beta-TrCP by molecular mimicry: a mechanism to inhibit NF-kappaB activation and promote immune evasion and virulence. PLoS Pathog 9: e1003183.
25. van Buuren N, Couturier B, Xiong Y, Barry M, (2008) Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex. J Virol 82: 9917–9927.
26. Mercer AA, Fleming SB, Ueda N, (2005) F-box-like domains are present in most poxvirus ankyrin repeat proteins. Virus Genes 31: 127–133.
27. Karin M, Ben-Neriah Y, (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621–663.
28. Tanaka K, Kawakami T, Tateishi K, Yashiroda H, Chiba T, (2001) Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie 83: 351–356.
29. Chang SJ, Hsiao JC, Sonnberg S, Chiang CT, Yang MH, et al. (2009) Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function. J Virol 83: 4140–4152.
30. Johnston JB, Wang G, Barrett JW, Nazarian SH, Colwill K, et al. (2005) Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J Virol 79: 10750–10763.
31. Mohamed MR, Rahman MM, Lanchbury JS, Shattuck D, Neff C, et al. (2009) Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A 106: 9045–9050.
32. Sonnberg S, Fleming SB, Mercer AA, (2009) A truncated two-alpha-helix F-box present in poxvirus ankyrin-repeat proteins is sufficient for binding the SCF1 ubiquitin ligase complex. J Gen Virol 90: 1224–1228.
33. Sonnberg S, Seet BT, Pawson T, Fleming SB, Mercer AA, (2008) Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc Natl Acad Sci U S A 105: 10955–10960.
34. Sperling KM, Schwantes A, Schnierle BS, Sutter G, (2008) The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex. Virology 374: 234–239.
35. Gammon DB, Gowrishankar B, Duraffour S, Andrei G, Upton C, et al. (2010) Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathog 6: e1000984.
36. Rintoul JL, Wang J, Gammon DB, van Buuren NJ, Garson K, et al. (2011) A selectable and excisable marker system for the rapid creation of recombinant poxviruses. PLoS One 6: e24643.
37. Ghosh S, May MJ, Kopp EB, (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225–260.
38. Hoffmann A, Natoli G, Ghosh G, (2006) Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706–6716.
39. Mohamed MR, Rahman MM, Rice A, Moyer RW, Werden SJ, et al. (2009) Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J Virol 83: 9223–9236.
40. Rubio D, Xu RH, Remakus S, Krouse TE, Truckenmiller ME, et al. (2013) Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection. Cell Host Microbe 13: 701–710.
41. Wilton BA, Campbell S, Van Buuren N, Garneau R, Furukawa M, et al. (2008) Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases. Virology 374: 82–99.
42. Wang Q, Burles K, Couturier B, Randall CM, Shisler J, et al. (2014) Ectromelia Virus Encodes a BTB/kelch Protein, EVM150, That Inhibits NF-kappaB Signaling. J Virol 88: 4853–4865.
43. Chaudhri G, Panchanathan V, Buller RM, van den Eertwegh AJ, Claassen E, et al. (2004) Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc Natl Acad Sci U S A 101: 9057–9062.
44. Esteban DJ, Buller RM, (2005) Ectromelia virus: the causative agent of mousepox. J Gen Virol 86: 2645–2659.
45. Parker S, Siddiqui AM, Oberle C, Hembrador E, Lanier R, et al. (2009) Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies. Virology 385: 11–21.
46. Rahman MM, McFadden G, (2011) Modulation of NF-kappaB signalling by microbial pathogens. Nat Rev Microbiol 9: 291–306.
47. Suzuki H, Chiba T, Kobayashi M, Takeuchi M, Suzuki T, et al. (1999) IkappaBalpha ubiquitination is catalyzed by an SCF-like complex containing Skp1, cullin-1, and two F-box/WD40-repeat proteins, betaTrCP1 and betaTrCP2. Biochem Biophys Res Commun 256: 127–132.
48. Perkus ME, Goebel SJ, Davis SW, Johnson GP, Norton EK, et al. (1991) Deletion of 55 open reading frames from the termini of vaccinia virus. Virology 180: 406–410.
49. Wyatt LS, Earl PL, Eller LA, Moss B, (2004) Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A 101: 4590–4595.
50. Fagan-Garcia K, Barry M, (2011) A vaccinia virus deletion mutant reveals the presence of additional inhibitors of NF-kappaB. J Virol 85: 883–894.
51. Oie KL, Pickup DJ, (2001) Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. Virology 288: 175–187.
52. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, et al. (1999) The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13: 270–283.
53. Besnard-Guerin C, Belaidouni N, Lassot I, Segeral E, Jobart A, et al. (2004) HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates. J Biol Chem 279: 788–795.
54. Lang V, Janzen J, Fischer GZ, Soneji Y, Beinke S, et al. (2003) betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol Cell Biol 23: 402–413.
55. Hsiao JC, Chao CC, Young MJ, Chang YT, Cho EC, et al. (2006) A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells. J Virol 80: 7714–7728.
56. Hsiao JC, Chung CS, Drillien R, Chang W, (2004) The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells. Virology 329: 199–212.
57. Frescas D, Pagano M, (2008) Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438–449.
58. Stuart D, Graham K, Schreiber M, Macaulay C, McFadden G, (1991) The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. J Virol 65: 61–70.
59. Michel JJ, Xiong Y, (1998) Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ 9: 435–449.
60. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM, (2007) Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81: 4070–4079.
61. Flesch IE, Hollett NA, Wong YC, Tscharke DC, (2012) Linear fidelity in quantification of anti-viral CD8+ T cells. PLoS One 7: e39533.